Biotech

All Articles

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has brought in a late entrance to the radioligand party, paying out 100 million europeans ($...

F 2G raises $100M for 2nd effort to receive brand-new antifungal to market

.After F2G's 1st effort to get a new lesson of antifungal to market was actually wrecked due to the ...

Moderna targets $1.1 B in R&ampD costs slices, falls 5 plans surrounded by profitability stress

.Moderna has pledged to reduce R&ampD spending through $1.1 billion by 2027. The choice to shrink th...

Sanofi's $80M bank on Key dystrophy medicine finishes in stage 3 lose big

.Merely four months after Sanofi bet $80 million in upfront cash money on Key Rehabs' losmapimod, th...

Oncternal assets sinks 60% among discharges, trial discontinuations

.Cancer cells firm Oncternal Therapeutics is actually folding all its clinical tests and also giving...

Roche is actually supporting out chances that its own injectable excessive weight possibility can at some point show 25% fat loss in late-stage trial

.Roche is holding out hopes that its injectable obesity possibility might inevitably display 25% eff...

Novo Nordisk barrages 'exceptional' weight loss result for dual-acting oral drug in very early trial

.Novo Nordisk has actually raised the top on a phase 1 trial of its own oral amylin and GLP-1 recept...

AbbVie files suit BeiGene over blood cancer medicine trade secrets

.Simply a handful of short weeks after gaining an FDA Fast Track tag for its investigational BTK deg...

Lilly delivers one-two blow along with second tranche of positive information on weekly blood insulin applicant

.Not long after a positive data decline for Eli Lilly's efsitora alfa, the Indianapolis-based provid...

BridgeBio reduces gene therapy budget plan as clinical data dissatisfy

.BridgeBio Pharma is slashing its gene therapy finances and drawing back coming from the technique a...